نتایج جستجو برای: fecal calprotectin

تعداد نتایج: 26991  

Journal: :Journal of Crohn's & colitis 2017
B Ungar A Lahat L Selinger N Levhar S Neuman U Kopylov M Yavzori E Fudim M Bubis O Picard R Eliakim S Ben-Horin

Prospectively-followed adalimumab-treated IBD patients performed a fecal calprotectin home-test (Buhlmann IBDoc), consisting of fecal collection, extraction and measurement by a smartphone app using the phone`s camera. Each patient performed the test under guidance by qualified personnel. The Quantum-Blue laboratory assay was performed simultaneously using the same stool sample for each patient.

2015
Thomas Flass Suhong Tong Daniel N. Frank Brandie D. Wagner Charles E. Robertson Cassandra Vogel Kotter Ronald J. Sokol Edith Zemanick Frank Accurso Edward J. Hoffenberg Michael R. Narkewicz

BACKGROUND AND AIMS Cirrhosis (CIR) occurs in 5-7% of cystic fibrosis (CF) patients. We hypothesized that alterations in intestinal function in CF contribute to the development of CIR. AIMS Determine the frequency of macroscopic intestinal lesions, intestinal inflammation, intestinal permeability and characterize fecal microbiome in CF CIR subjects and CF subjects with no liver disease (CFnoL...

Journal: :middle east journal of digestive diseases 0
vahid basirat zahra azizi sanam javid-anbardan mina taghizadehasl yasaman farbod azam teimouri

introduction due to limitation of colonoscopy in assessing the entire bowel and patients’ intolerance in inflammatory bowel disease (ibd), in the current study, we aimed to prospectively compare the accuracy of 99m tc(v)-dimercaptosuccinic acid (dmsa) and fecal calprotectin with ileocolonoscopy as new methods for localizing inflammations. methods current prospective study conducted between 2012...

Background: Inflammatory bowel disease (IBD) involves chronic inflammation of the digestive tract. In the past decades, fecal calprotectin has been proposed as a useful biomarker for the differential diagnosis between IBD patients and healthy controls. We designed this study to evaluate the diagnostic ability of fecal calprotectin (FC) and conventional inflammatory markers in IBD patients. M...

Journal: :European review for medical and pharmacological sciences 2013
J Walkowiak S Cofta R Mozrzymas Z Siwinska-Mrozek J Nowak L Kaluzny T Banasiewicz

BACKGROUND Phenylketonuria (PKU) is an inborn error of amino acid metabolism in which high phenylalanine (Phe) concentrations in the central nervous system adversely affect its development and functioning. In PKU high oxidative stress and inefficiency of free radical scavenging may lead to systemic chronic inflammation. We hypothesised that in PKU gut mucosa is chronically inflamed and that thi...

2015
Laura Moles Esperanza Escribano Javier de Andrés María Teresa Montes Juan M Rodríguez Esther Jiménez Miguel Sáenz de Pipaón Irene Espinosa-Martos

The preterm infant gut has been described as immature and colonized by an aberrant microbiota. Therefore, the use of probiotics is an attractive practice in hospitals to try to reduce morbidity and mortality in this population. The objective of this pilot study was to elucidate if administration of two probiotic strains isolated from human milk to preterm infants led to their presence in feces....

2017
Fiona C Malcomson Naomi D Willis Iain McCallum Long Xie Idoia Ibero-Baraibar Wing C Leung Seamus Kelly D Michael Bradburn Nigel J Belshaw Ian T Johnson John C Mathers

BACKGROUND Hyperactive Wnt signaling is frequently observed in colorectal cancer. Higher intakes of dietary fiber [nondigestible carbohydrates (NDCs)] and the fermentation product butyrate are protective against colorectal cancer and may exert their preventative effects via modulation of the Wnt pathway. OBJECTIVES We investigated the effects of supplementing healthy individuals with 2 NDCs [...

2014
Lise Pedersen Mads Nybo Mikael Kjær Poulsen Jan Erik Henriksen Jordi Dahl Lars Melholt Rasmussen

BACKGROUND Plasma calprotectin is a potential biomarker of cardiovascular disease (CVD), insulin resistance (IR), and obesity. We examined the relationship between plasma calprotectin concentrations, CVD manifestations and the metabolic syndrome (MetS) in patients with type 2 diabetes mellitus (T2DM) in order to evaluate plasma calprotectin as a risk assessor of CVD in diabetic patients without...

Journal: :Clinical and Experimental Gastroenterology 2016

2013
Kaija-Leena Kolho Dan Turner

Objective. To explore fecal calprotectin levels in pediatric ulcerative colitis (UC) in relation with the validated clinical activity index PUCAI. Methods. This study included all 37 children (median age 14 years) with UC who had calprotectin measured (PhiCal ELISA Test) by the time of PUCAI assessment at the Children's Hospital of Helsinki in a total of 62 visits. Calprotectin values <100  μ g...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید